Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.

Hou, Ming-Mo

Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. [electronic resource] - Oncotarget Jun 2016 - 35132-43 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.9048 doi


Adult
Aged
Angiogenesis Inhibitors--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Ovarian Epithelial
Clinical Trials, Phase I as Topic
Disease Progression
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasms, Glandular and Epithelial--drug therapy
Ovarian Neoplasms--drug therapy
Proportional Hazards Models
Retrospective Studies
Treatment Outcome